Abstract
Chemed Corporation will report third-quarter results on October 27, 2026 Post-Mkt, with consensus indicating revenue of 685.04 million US dollars and adjusted EPS of 6.44, while investors watch how VITAS volume and pricing plus recent Roto-Rooter franchise expansion shape margins and guidance.
Market Forecast
Consensus points to third-quarter revenue of 685.04 million US dollars, up 9.43% year over year, with adjusted EPS estimated at 6.44, up 20.19%; EBIT is modeled at 112.40 million US dollars, up 16.65% year over year. The company has not issued margin guidance for the quarter, so gross profit and net margin forecasts are not cited, though prior-quarter margins provide a baseline for comparison.
Highlights and outlook of the main business emphasize steady patient volume and pricing in VITAS supported by management’s full-year framework. The most promising segment remains VITAS, which generated 443.34 million US dollars last quarter and is tracked against a full-year growth framework pointing toward high single-digit revenue expansion for 2026, in line with the company’s updated guidance cadence for volume and revenue growth.
Last Quarter Review
Chemed’s previous quarter delivered revenue of 673.25 million US dollars, a gross profit margin of 32.90%, GAAP net profit attributable to the parent company of 67.70 million US dollars, a net profit margin of 10.06%, and adjusted EPS of 6.06, up 41.92% year over year; company revenue grew 8.80% year over year, and net profit rose 2.11% sequentially.
A key financial highlight was the adjusted EPS outperformance against consensus alongside an upwardly revised full-year EPS outlook. Main business contributions were led by VITAS at 443.34 million US dollars and Roto-Rooter at 229.91 million US dollars, with the mix aligning to healthy overall growth and profitability improvements compared with the prior-year period.
Current Quarter Outlook
Main business performance and profit drivers: VITAS
VITAS remains the core earnings engine this quarter, underpinned by stable admissions, improving average daily census, and disciplined pricing. Management’s framework for 2026 includes volume growth in the mid-single-digit range and revenue growth in the high single-digit range after excluding the Medicare cap effect, which aligns closely with third-quarter consensus revenue growth of 9.43%. Operationally, staffing stabilization and clinician retention trends are expected to support service intensity and visit compliance, which should translate to more consistent revenue recognition and a supportive cost-to-serve profile through the quarter. While there is no formal quarterly margin guide, last quarter’s consolidated gross profit margin of 32.90% and net margin of 10.06% offer a performance baseline; incremental scale at VITAS can support fixed-cost absorption, contributing to EBIT growth modeled at 16.65% year over year.
Pricing dynamics within the period are likely to reflect payer rate updates and acuity mix, with a balanced contribution from routine home care and higher-acuity days. This mix will be watched in connection with service utilization and potential case-mix shifts, as it can influence revenue per patient day. The interplay between clinician cost trends, overtime moderation, and recruitment pipelines is another swing factor; continued progress here generally reduces per-visit costs and helps preserve margin as volumes grow. Additionally, management’s full-year cadence signals confidence that revenue growth can be sustained in line with volume and price, reinforcing the consensus view that adjusted EPS can advance by approximately 20.19% year over year in the third quarter.
From a cash flow perspective, working capital typically follows revenue cadence with modest timing noise from payor cycles and settlements. The quarter’s earnings trajectory thus leans on growth in patient days and a steady pricing environment, while operational efficiency and cost controls remain key levers to sustain returns. Any variance from consensus is likely to reflect short-term shifts in visit intensity, staffing mix, or timing in revenue recognition rather than structural changes to growth algorithms implied by the full-year outlook.
Most promising business this quarter: Roto-Rooter
Roto-Rooter continues to be a constructive earnings contributor with broad geographic footprint and a mix of residential and commercial demand. The segment posted 229.91 million US dollars of revenue last quarter, and recent territory expansion via the acquisition of a large franchise area in California adds a quantifiable growth lever, especially in densely populated markets. Integrating this new footprint can drive incremental revenue through brand coverage, digital lead conversion, and cross-sell of ancillary services, with the near-term emphasis on deploying field capacity, aligning call-center operations, and optimizing route efficiencies. While the immediate EBIT uplift is contingent on ramp timing, the acquisition supports a higher medium-term run rate for both revenue and contribution margin as utilization scales.
Seasonality and one-off event work can add variability quarter to quarter, but the expanded service map increases exposure to high-density urban and suburban corridors where call volumes and ticket values tend to be favorable. Pricing discipline and service mix—such as higher-margin trenchless repair or water restoration—can accentuate margin performance. The operational thesis is that platform scale combined with standardized processes and marketing funnel efficiency yields accretive economics over time, which can complement VITAS-driven growth at the consolidated level.
Given that consolidated EBIT is forecast at 112.40 million US dollars, up 16.65% year over year, incremental Roto-Rooter contribution represents a potential upside vector if integration and call volume conversion outpace expectations. Investors will monitor commentary on service backlog, staffing levels, route productivity, and early-margin trajectory from the newly acquired territories to assess how quickly the deal translates into reported earnings.
Key factors likely to move the stock this quarter
Consensus for adjusted EPS at 6.44 implies continued operating leverage, and the core catalysts will be revenue growth realization and cost control consistency. On the revenue side, the magnitude of VITAS volume growth versus price mix will influence whether top-line growth tracks or beats the projected 9.43% year-over-year increase. On the cost side, further normalization of labor markets, consistent scheduling efficiency, and reduced reliance on premium pay can preserve or expand margins. Small changes in visit intensity or case mix can have a measurable impact on margin given the service model’s operating leverage, so qualitative management commentary on staffing and patient flow will be interpreted closely.
Roto-Rooter’s near-term integration of newly acquired territories is another swing factor; early positive signals on call conversion rates, technician utilization, and average ticket sizes can reinforce confidence in the EBIT trajectory. Conversely, any slower-than-expected ramp or short-term integration costs would likely be framed as timing rather than trend issues if management reiterates the broader revenue and earnings cadence for 2026. In aggregate, the setup into the print centers on whether consolidated revenue lands near 685.04 million US dollars and whether consolidated profitability shows sequential continuity with last quarter’s 32.90% gross margin and 10.06% net margin as references, recognizing that margin outcomes are not explicitly guided.
Finally, the full-year adjusted EPS framework of 25.00 to 25.75, communicated earlier, sets an expectations anchor. Delivering a third quarter in line with consensus, while reiterating or tightening the full-year range, would be viewed as confirmation of execution and cost discipline. Beyond earnings, capital deployment updates—such as share repurchases, dividends, or additional tuck-in transactions—can also shape sentiment, especially if aligned with a sustained free cash flow trajectory.
Analyst Opinions
Bullish views currently outnumber bearish ones among recently cited opinions, with the balance of commentary leaning positive on revenue and EPS momentum into the third quarter. Based on the collected views within the period, the ratio of bullish to bearish opinions stands at 1 to 0. The bullish perspective emphasizes that consensus calls for revenue of 685.04 million US dollars, up 9.43% year over year, and adjusted EPS of 6.44, up 20.19%. One prominent institution has a Buy stance with a price target of 650, highlighting confidence in both VITAS growth and incremental upside from Roto-Rooter’s footprint expansion. Another widely followed institution raised its price target while retaining a neutral stance, which still underscores improved earnings power compared with prior quarters.
The core bullish thesis centers on three elements. First, the earnings cadence: year-over-year growth in revenue and adjusted EPS is supported by visible drivers—volume and pricing at VITAS, alongside incremental capacity and territory expansion at Roto-Rooter. Second, execution memory: last quarter’s performance delivered 673.25 million US dollars of revenue and adjusted EPS of 6.06, with margins at 32.90% gross and 10.06% net, providing evidence that cost controls and operational initiatives are translating to profit. Third, forward guardrails: management’s full-year framework for volume and revenue growth at VITAS and the prior EPS outlook posture provide a reasonable boundary for consensus estimates, which reduces the likelihood of a material deviation if operating conditions remain stable.
Bullish analysts also point to EBIT modeled at 112.40 million US dollars, up 16.65% year over year, as a signal that operating leverage is working despite ongoing investment in staffing and service capacity. The recent acquisition of a large California franchise territory by Roto-Rooter is seen as both a strategic and financial positive, broadening the revenue base and potentially improving medium-term margin through scale economics. Investors tracking these elements may give management credit for a balanced approach to growth and profitability, which informs constructive ratings and upward revisions to price targets by selected institutions.
In interpreting the current setup, bullish observers acknowledge typical reporting-quarter uncertainties such as case-mix and visit-intensity variability but argue that the mosaic of data—volume growth, pricing discipline, and expense management—continues to support double-digit adjusted EPS growth. The alignment between management’s full-year guardrails and consensus estimates further underpins the positive stance. Should the company deliver revenue close to 685.04 million US dollars and adjusted EPS near 6.44 while maintaining commentary consistent with the existing full-year outline, bulls expect the narrative to remain supportive for the shares.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments